Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT02079246

Public ClinicalTrials.gov record NCT02079246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Study identification

NCT ID
NCT02079246
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
1,463 participants

Conditions and interventions

Interventions

  • Idalopirdine 60 mg Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2014
Primary completion
Jul 5, 2017
Completion
Jul 5, 2017
Last update posted
Aug 9, 2018

2014 – 2017

United States locations

U.S. sites
64
U.S. states
27
U.S. cities
59
Facility City State ZIP Site status
US027 Birmingham Alabama
US012 Phoenix Arizona
US338 Phoenix Arizona
US024 Little Rock Arkansas
US351 Carlsbad California
US346 Costa Mesa California
US327 Fullerton California
US023 Imperial California
US045 Long Beach California
US307 Redlands California
US058 San Francisco California
US018 Santa Ana California
US301 Santa Rosa California
US021 Bradenton Florida
US050 Brooksville Florida
US308 Delray Beach Florida
US320 Hallandale Florida
US347 Hialeah Florida
US340 Lake Worth Florida
US303 Miami Florida
US313 Miami Florida
US345 Orange City Florida
US019 Orlando Florida
US309 Palm Beach Gardens Florida
US038 Port Charlotte Florida
US302 Sunrise Florida
US304 Atlanta Georgia
US360 Augusta Georgia
US048 Kailua Hawaii
US030 Chicago Illinois
US040 Indianapolis Indiana
US334 Lake Charles Louisiana
US036 Freeport Maine
US344 Boston Massachusetts
US035 Kalamazoo Michigan
US310 Saint Paul Minnesota
US041 Flowood Mississippi
US321 Hattiesburg Mississippi
US339 Paterson New Jersey
US046 Princeton New Jersey
US028 Toms River New Jersey
US044 Toms River New Jersey
US014 Manhasset New York 11030
US029 New York New York
US312 Staten Island New York
US316 Charlotte North Carolina
US336 Winston-Salem North Carolina
US007 Centerville Ohio
US323 Cincinnati Ohio
US006 Columbus Ohio
US306 Columbus Ohio
US352 Lakewood Ohio
US333 Oklahoma City Oklahoma
US026 Portland Oregon
US057 Jenkintown Pennsylvania
US324 Pittsburgh Pennsylvania
US341 Pittsburgh Pennsylvania
US319 Port Royal South Carolina
US356 Cordova Tennessee
US343 Fort Worth Texas
US354 Houston Texas
US047 Arlington Virginia
US025 Madison Wisconsin
US004 Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 194 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02079246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2018 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02079246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →